Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Seccombe

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|December 18, 1982
L-carnitine for methylmalonicaciduriaD W Seccombe, F Snyder, H G Parsons
Journal of Forensic Sciences|May 1, 1987
Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicityD W Seccombe, M R Pudek, K H Humphries
Clinical Biochemistry|February 1, 1989
The role of apoproteins in disorders of lipoprotein metabolismJ J Frohlich, D W Seccombe, P H Pritchard
Clinical Chemistry|August 1, 1987
Endogenous digoxin-like immunoreactive substances eliminated from serum samples from patients with liver disease by the EMIT column digoxin assayI A Kulaots, M R Pudek, D W Seccombe
Metabolism: Clinical and Experimental|December 1, 1987
L-carnitine treatment in the hyperlipidemic rabbitD W Seccombe, L James, P Hahn, et al.
Clinical Pharmacy|May 1, 1984
Interference with serum digoxin assays in neonatesM Levine, S Gill, D W Seccombe, et al.
Clinical Biochemistry|February 1, 1989
Digoxin-like immunoreactivity, displacement of ouabain and inhibition of Na+/K+ ATPase by four steroids known to be increased in essential hypertensionD W Seccombe, M R Pudek, W Nowaczynski, et al.
Clinical Biochemistry|November 14, 2000
A study to examine the accuracy of potassium measurements in clinical laboratories across CanadaM D Haag, J R Kelly, A Ho, et al.
Metabolism: Clinical and Experimental|September 1, 1995
Effects of high-fat diet and fasting on levels of acyl-coenzyme A binding protein in liver, kidney, and heart of ratJ Bhuiyan, P H Pritchard, S V Pande, et al.
The New England Journal of Medicine|April 14, 1983
Digoxin-like immunoreactivity in premature and full-term infants not receiving digoxin therapyM R Pudek, D W Seccombe, M F Whitfield, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|December 18, 1982
L-carnitine for methylmalonicaciduriaD W Seccombe, F Snyder, H G Parsons
Journal of Forensic Sciences|May 1, 1987
Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicityD W Seccombe, M R Pudek, K H Humphries
Clinical Biochemistry|February 1, 1989
The role of apoproteins in disorders of lipoprotein metabolismJ J Frohlich, D W Seccombe, P H Pritchard
Clinical Chemistry|August 1, 1987
Endogenous digoxin-like immunoreactive substances eliminated from serum samples from patients with liver disease by the EMIT column digoxin assayI A Kulaots, M R Pudek, D W Seccombe
Metabolism: Clinical and Experimental|December 1, 1987
L-carnitine treatment in the hyperlipidemic rabbitD W Seccombe, L James, P Hahn, et al.
Clinical Pharmacy|May 1, 1984
Interference with serum digoxin assays in neonatesM Levine, S Gill, D W Seccombe, et al.
Clinical Biochemistry|February 1, 1989
Digoxin-like immunoreactivity, displacement of ouabain and inhibition of Na+/K+ ATPase by four steroids known to be increased in essential hypertensionD W Seccombe, M R Pudek, W Nowaczynski, et al.
Clinical Biochemistry|November 14, 2000
A study to examine the accuracy of potassium measurements in clinical laboratories across CanadaM D Haag, J R Kelly, A Ho, et al.
Metabolism: Clinical and Experimental|September 1, 1995
Effects of high-fat diet and fasting on levels of acyl-coenzyme A binding protein in liver, kidney, and heart of ratJ Bhuiyan, P H Pritchard, S V Pande, et al.
The New England Journal of Medicine|April 14, 1983
Digoxin-like immunoreactivity in premature and full-term infants not receiving digoxin therapyM R Pudek, D W Seccombe, M F Whitfield, et al.
Pageof 4